DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Hematopoietic cell lineage	R-HSA-173752	map04640	levomepromazine	65863	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	levomepromazine	65863	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	levomepromazine	65863	drug-path
Olfactory transduction	R-HSA-9751605	map04740	levomepromazine	65863	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	levomepromazine	65863	drug-path
Asthma	R-HSA-444620	map05310	levomepromazine	65863	drug-path
Allograft rejection	R-HSA-9679028	map05330	levomepromazine	65863	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	levomepromazine	65863	drug-path
Allograft rejection	R-HSA-9679028	map05330	sulfamonomethoxine	5332	drug-path
Shigellosis	0	map05131	sulfamonomethoxine	5332	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	sulfamonomethoxine	5332	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	ifosfamide	4839	drug-path
Pathways in cancer	R-HSA-9824443	map05200	ifosfamide	4839	drug-path
Olfactory transduction	R-HSA-9751605	map04740	ifosfamide	4839	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	ifosfamide	4839	drug-path
Bladder cancer	R-HSA-9700206	map05219	ifosfamide	4839	drug-path
Ribosome	R-HSA-5368277	map03010	ifosfamide	4839	drug-path
Olfactory transduction	R-HSA-9751605	map04740	pralidoxime	135398747	drug-path
TGF-beta signaling pathway	R-HSA-168638	map04350	pralidoxime	135398747	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	pralidoxime	135398747	drug-path